{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:26:50Z","timestamp":1787063210886,"version":"build-2736575974"},"reference-count":30,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.9677","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T05:28:42Z","timestamp":1611293322000},"source":"Crossref","is-referenced-by-count":8,"title":["Successful treatment of Gaucher disease type 1 by enzyme replacement therapy over a 10-year duration in a Japanese pediatric patient: A case report"],"prefix":"10.3892","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0130-0585","authenticated-orcid":false,"given":"Yuji","family":"Oto","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Itabashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Shiraisihi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ida","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo 105-8471, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"key20220302134006_b1-etm-0-0-09677","first-page":"72","article-title":"Gaucher disease: The metabolic defect, pathophysiology, phenotypes and natural history","volume":"12 (Suppl 1)","author":"Baris","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"key20220302134006_b2-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/s0950-3536(97)80033-9","article-title":"Gaucher's disease: Clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"key20220302134006_b3-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/bjh.12804","article-title":"Gaucher disease: Haematological presentations and complications","volume":"165","author":"Thomas","year":"2014","journal-title":"Br J Haematol"},{"key":"key20220302134006_b4-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum Mutat"},{"key":"key20220302134006_b5-etm-0-0-09677","author":"Eto"},{"key":"key20220302134006_b6-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ymgme.2006.09.003","article-title":"The long-term international safety experience of imiglucerase therapy for Gaucher disease","volume":"90","author":"Starzyk","year":"2007","journal-title":"Mol Genet Metab"},{"key":"key20220302134006_b7-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum Genet"},{"key":"key20220302134006_b8-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ymgme.2009.05.001","article-title":"Clinical and genetic study of Japanese patients with type 3 Gaucher disease","volume":"97","author":"Tajima","year":"2009","journal-title":"Mol Genet Metab"},{"key":"key20220302134006_b9-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/a:1005313724361","article-title":"Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: Identification of four novel mutations","volume":"20","author":"Ida","year":"1997","journal-title":"J Inherit Metab Dis"},{"key":"key20220302134006_b10-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1542\/peds.2007-2144","article-title":"Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1","volume":"122","author":"Andersson","year":"2008","journal-title":"Pediatrics"},{"key":"key20220302134006_b11-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: A novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"key20220302134006_b12-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"key20220302134006_b13-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"E140","DOI":"10.1002\/ajh.25074","article-title":"Glucosylsphingosine is a reliable response biomarker in Gaucher disease","volume":"93","author":"Arkadir","year":"2018","journal-title":"Am J Hematol"},{"key":"key20220302134006_b14-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/pl00008411","article-title":"Effects of enzyme replacement therapy in thirteen Japanese paediatric patients with Gaucher disease","volume":"160","author":"Ida","year":"2001","journal-title":"Eur J Pediatr"},{"key":"key20220302134006_b15-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/GIM.0b013e31818e2c19","article-title":"Dose-response relationships for enzyme replacement therapy with imiglucerase\/alglucerase in patients with Gaucher disease type 1","volume":"11","author":"Grabowski","year":"2009","journal-title":"Genet Med"},{"key":"key20220302134006_b16-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: A review","volume":"75 (Suppl 1)","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol"},{"key":"key20220302134006_b17-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bcmd.2016.11.014","article-title":"Growth and final height of children with Gaucher disease: A 15-year follow-up at an Israeli Gaucher center","volume":"68","author":"Mendelsohn","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"key20220302134006_b18-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2214\/AJR.06.1410","article-title":"Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score","volume":"188","author":"Robertson","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"key20220302134006_b19-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1185\/030079906X104623","article-title":"Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients","volume":"22","author":"Vom Dahl","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"key20220302134006_b20-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jbmr.3734","article-title":"Gaucher Disease in Bone: From Pathophysiology to Practice","volume":"34","author":"Hughes","year":"2019","journal-title":"J Bone Miner Res"},{"key":"key20220302134006_b21-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10545-012-9528-4","article-title":"Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment","volume":"36","author":"Weinreb","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"key20220302134006_b22-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1399-0004.2007.00769.x","article-title":"The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease","volume":"71","author":"Charrow","year":"2007","journal-title":"Clin Genet"},{"key":"key20220302134006_b23-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: Results of a 48-month longitudinal cohort study","volume":"73","author":"Sims","year":"2008","journal-title":"Clin Genet"},{"key":"key20220302134006_b24-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s002560100375","article-title":"Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: First German long-term results","volume":"30","author":"Poll","year":"2001","journal-title":"Skeletal Radiol"},{"key":"key20220302134006_b25-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"A25","DOI":"10.1259\/bjr.75.suppl_1.750025","article-title":"Response of Gaucher bone disease to enzyme replacement therapy","volume":"75 (Suppl 1)","author":"Poll","year":"2002","journal-title":"Br J Radiol"},{"key":"key20220302134006_b26-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/labinvest.3780345","article-title":"Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: A possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses","volume":"81","author":"Simonaro","year":"2001","journal-title":"Lab Invest"},{"key":"key20220302134006_b27-etm-0-0-09677","first-page":"921","article-title":"Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients","volume":"53","author":"Horowitz","year":"1993","journal-title":"Am J Hum Genet"},{"key":"key20220302134006_b28-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/geno.1993.1035","article-title":"Identification of six new Gaucher disease mutations","volume":"15","author":"Beutler","year":"1993","journal-title":"Genomics"},{"key":"key20220302134006_b29-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/bcmd.1998.0172","article-title":"Type 1 Gaucher disease: Phenotypic expression and natural history in Japanese patients","volume":"24","author":"Ida","year":"1998","journal-title":"Blood Cells Mol Dis"},{"key":"key20220302134006_b30-etm-0-0-09677","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s004399900076","article-title":"Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation","volume":"105","author":"Ida","year":"1999","journal-title":"J Hum Genet"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T06:43:17Z","timestamp":1646203397000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.9677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,1,22]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.9677","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"article-number":"246"}}